172 Overcoming immunosuppressive TGF-β signaling in human ovarian cancer-derived tumor infiltrating lymphocytes via non-viral CRISPR engineering
Samantha M. Fix(The University of Texas MD Anderson Cancer Center), Amir A. Jazaeri(The University of Texas MD Anderson Cancer Center), Ana Lucía Dominguez(The University of Texas MD Anderson Cancer Center), Rafet Başar(The University of Texas MD Anderson Cancer Center), Patrick Hwu(Moffitt Cancer Center), Donastas Sakellariou-Thompson(The University of Texas MD Anderson Cancer Center), Sanjay Kumar(Uttarakhand State Council for Science and Technology), Chantale Bernatchez(BMC Software (United States)), Yunfei Wang(The University of Texas MD Anderson Cancer Center), Larissa A. Meyer, Christopher Reyes(Thermo Fisher Scientific (United States)), Marie‐Andrée Forget(The University of Texas MD Anderson Cancer Center)
Cited by 1
Related Papers
Breast cancer classification and prognosis based on gene expression profiles from a population-based study
|Proceedings of the National Academy of Sciences|2003|2k
A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade
|Cell|2018|1.5k
BRAF Inhibition Is Associated with Enhanced Melanoma Antigen Expression and a More Favorable Tumor Microenvironment in Patients with Metastatic Melanoma
|Clinical Cancer Research|2013|938
Mechanics, malignancy, and metastasis: The force journey of a tumor cell
|Cancer and Metastasis Reviews|2009|924
Microtubules can bear enhanced compressive loads in living cells because of lateral reinforcement
|The Journal of Cell Biology|2006|707